Cargando…
Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells
Somatostatin analogs, which are used to treat neuroendocrine tumors, inhibit hormone secretion or promote tumor shrinkage; however, their efficacy varies between patients, possibly because of differential expression of somatostatin receptors (SSTRs) in tumors. In this study, we evaluated the regulat...
Autores principales: | Jo, HanHee, Park, Yusun, Kim, Jisu, Kwon, Hyeonjeong, Kim, Taehun, Lee, JongSook, Pyun, Jae-Chul, Lee, Misu, Yun, Mijin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549806/ https://www.ncbi.nlm.nih.gov/pubmed/33045023 http://dx.doi.org/10.1371/journal.pone.0240107 |
Ejemplares similares
-
Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
por: Jo, Hanhee, et al.
Publicado: (2020) -
Modified parylene-N films as chemical microenvironments for differentiation and spheroid formation of osteoblast cells
por: Kim, Tae-Hun, et al.
Publicado: (2020) -
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia
por: Jo, Hanhee, et al.
Publicado: (2020) -
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021) -
Role of Somatostatin Signalling in Neuroendocrine Tumours
por: Rogoza, Olesja, et al.
Publicado: (2022)